Researchers have shown that activation of the protein YAP, which helps tumours grow, differs between two- and three-dimensional culture models, pointing to more predictive systems for testing cancer ...

non-small cell lung cancer, pancreatic cancer and MIBC." 1 Llano A, Chan A, Kuk C, Kassouf W, Zlotta AR. Carcinoma In Situ (CIS): Is There a Difference in Efficacy between Various BCG Strains? A ...

Lung cancer is one of the most common cancers. Stage 1 lung cancer is defined by tumors that are very small and have not spread (metastasized) to other parts of the body. Despite its name, it is ...

The study presents positive preclinical data for the treatment of KRASG12C mutant non-small cell lung cancer (NSCLC). The research, which will be detailed in a poster presentation at the upcoming 2025 ...

non-small cell lung cancer, pancreatic cancer and MIBC." Theralase® is a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or ...

Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal ... National Heart, Lung, and Blood Institute. Iron-deficiency anemia. Abuga KM, Nairz M, MacLennan ...

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with ...